Thymosin Alpha-1

🔹 What is Thymosin Alpha-1?

Class: Synthetic peptide fragment derived from thymosin fraction 5, originally isolated from the thymus gland. Mechanism: Enhances T-cell function, increases immune surveillance, modulates cytokine production, and reduces chronic inflammation. TA1 also functions as a genuine senolytic agent — it directly supports apoptosis of senescent (“zombie”) cells, upregulates glutathione, and improves cellular redox balance. It initiates IL-10 transcription, contributing to a broader “senomodulation” effect on the immune system. Mechanistically, senescent cells use a kind of molecular camouflage to evade immune detection; TA1 helps strip that camouflage away, improving the ability of natural killer (NK) cells to find and clear senescent cells. Primary focus: Immune optimization, anti-viral defense, cancer immunotherapy support, cellular senescence/senolytic support, and reducing chronic low-grade inflammation.

---

🔹 Oral Dosage (least common)

Range studied/used in research: Rarely oral — poor bioavailability. Typical protocol:

• 2–3 mg orally daily (experimental use, very limited data).
• Often paired with liposomal delivery systems to improve absorption.

Notes: Injectable form is far more reliable and widely used in research.

---

🔹 Injectable Dosage (subcutaneous – most common)

Range: 1.5–3 mg, 2–3x per week (some protocols go up to 4.5 mg, 3x/week). Frequency: Every other day or 2–3x weekly depending on immune status and research goals. Rationale: Direct subQ bypasses degradation, ensuring strong immunomodulatory effect.

Real-world compounded example: 15 mg vial, dosed at 450 mcg SQ daily for 30 days, for immune modulation.

---

🔹 Intranasal Dosage

Real-world compounded example: 2,000 mcg/ml (15 ml nasal spray bottle) — dosed at 1–2 sprays intranasally daily or as needed, for immune modulation. Notes: A non-invasive alternative to the injectable route for ongoing immune support.

---

🔹 Cycle Length

Common cycle length: 6–12 weeks for immune system support. Off-cycle: Often paused after protocol completion; may be reintroduced seasonally (e.g., during flu season) or post-infection recovery. Special note: In chronic immune conditions, some research protocols use ongoing low-dose maintenance.

---

🔹 Optimal Dosing Window

Oral:

• Not commonly used due to poor bioavailability.

Injectable:

• Morning or early afternoon dosing preferred.
• Avoid late-evening injections in sensitive individuals (immune activity can sometimes interfere with sleep).

---

✅ Educational Integration Example (oral):

• 3 mg liposomal oral formulation daily.
• Run for 8 weeks during seasonal immune challenges.

✅ Educational Integration Example (injectable):

• 1.5 mg subQ Mon/Wed/Fri for 10 weeks.
• Pair with lifestyle immune support (Vitamin D, zinc, sleep optimization).

---

🔹 Stacking Strategy (Educational)

Since Thymosin Alpha-1 enhances immune surveillance and balances inflammation, stacks should complement immune resilience and recovery:

🔸 Immune & Viral Defense

• Thymosin Beta-4 (TB-500) – synergistic tissue repair + immune modulation. TA1 and TB4 are frequently framed together as a complementary immune/senescence-fighting pair — TA1 driving senolytic clearance and immune surveillance while TB4 drives tissue repair.
• LL-37 – antimicrobial peptide for bacterial/viral protection.
• Selank – anxiolytic peptide that also supports immune balance.

🔸 Recovery & Anti-Inflammatory Support

• BPC-157 – gut + systemic healing, pairs well with immune balance.
• GHK-Cu – anti-inflammatory and regenerative synergy.
• Low-dose naltrexone (LDN, experimental) – immune modulation in chronic conditions.

🔸 Anti-Aging / Longevity Stack

• Thymosin Alpha-1 + Epitalon (pineal peptide for longevity)
• Add-on: GH secretagogues (Ipamorelin + CJC-1295) to support thymic and immune rejuvenation.

Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.